2026

Vancouver, British Columbia and Rehovot, Israel – June 18, 2026 – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details: BioHarvest Sciences’ presentation will showcase […]

Expanded sweetener molecule development program aims to broaden access to plant‑based sweetening solutions tailored to diverse customer food and beverage categories. Vancouver, British Columbia and Rehovot, Israel – May 18th, 2026 – BioHarvest Sciences Inc. (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis™ technology and sustainable plant-based molecule development, today announced the expansion of

– CDMO program advances to Stage 2 of development agreement valued at $1.125 million -Advancement of sustainable solution for the production of saffron, one of the world’s most valuable and health-promoting botanicals – In addition to future commercial manufacturing royalties, BioHarvest also holds a 25% ownership position in Saffron Composition   Vancouver, British Columbia and

Source plant is widely regarded as one of the most valuable fragrance raw materials in the world Stage 2 contract follows successful Stage 1 completion in March 2026 Vancouver, British Columbia and Rehovot, Israel— (May 12, 2026) – BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a leader in Botanical Synthesis technology

Ilan Sobel joins Board of Directors with focused mandate on D2C growth.Dr. Zaki Rakib, Co-Founder and Executive Chairman, assumes role of Chief Executive Officer, Integrating R&D, Manufacturing, and Operations under the CDMO. Vancouver, British Columbia and Rehovot, Israel – April 29, 2026 – BioHarvest Sciences Inc. (Nasdaq: BHST) (FSE: 8MV0) (“BioHarvest” or the “Company”), a